In addition, Cua et al. showed that IL-23p19-/- mice characterized by an IL-17 deficiency, were resistant to experimental autoimmune brain inflammation, suggesting IL-23 (and thereby IL-17) as a crucial cytokine in autoimmune CNS diseases [38]. This evidence concerns the gene IL17A and hyperinsulinemic hypoglycemia, familial, 4.